Covid Vaccine Data for Kids Under 5 May Come in Late October Says Pfizer CEO

Posted on

The world is still grappling with the coronavirus and many parents are anticipating when they can get their kids vaccinated.

Pfizer CEO Albert Bourla said this week that Covid vaccine data for kids age under 5 may come in late October.

The company expects to release clinical trial data on how well its Covid-19 vaccine works in 6-month to 5-year-old children next month.

Covid vaccine data for kids between ages 5 and 11 will come much sooner said the CEO. It will potentially be ready to be submitted to the FDA by the end of this month.

“Then, it is up to the FDA to take their time, and then make a decision,” Bourla said during an interview at Research! America’s 2021 National Health Research Forum.

So far, the Pfizer-BioNTech coronavirus vaccine has been cleared by the FDA for people as young as 12,.

On Friday, FDA officials said they were “working around the clock” to support the approvals of Covid vaccines for kids under age 12.

Dr. Peter Marks, the FDA’s top vaccine regulator said in August that the agency would move as “swiftly” as possible on approving the shot for kids under 12 once the companies submit data.

“Currently, there are still trials ongoing and so the agency has to wait for the company to submit the data for those trials,” he said Aug. 23. “We certainly want to make sure that we get it right.”

Disclaimer: We have no position in any of the companies mentioned and have not been compensated for this article.

Daily updates